Stockholders’ Equity (Details) - USD ($)
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
|
|
|
|
|
|
May 06, 2026 |
May 05, 2026 |
Mar. 24, 2026 |
Dec. 10, 2025 |
Dec. 08, 2025 |
Sep. 19, 2025 |
Sep. 10, 2025 |
Jul. 17, 2025 |
Dec. 31, 2025 |
Sep. 30, 2025 |
Jul. 31, 2025 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Feb. 18, 2026 |
Oct. 27, 2025 |
Apr. 07, 2025 |
Aug. 05, 2024 |
Aug. 02, 2024 |
Apr. 29, 2023 |
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock authorized |
|
|
|
|
|
|
|
|
|
400,000,000
|
|
400,000,000
|
|
|
400,000,000
|
|
|
|
|
110,000,000
|
|
|
| Common stock par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
| Preferred stock authorized |
|
|
|
|
|
|
|
|
|
10,000,000
|
|
10,000,000
|
|
|
10,000,000
|
|
|
|
|
|
|
|
| Preferred stock par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
|
|
25,555,556
|
|
|
25,555,556
|
|
|
|
|
|
|
|
| Expire date |
|
|
|
Jan. 20, 2031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
|
|
|
|
$ 7,546,988
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
$ 749,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expenses of placement agent fee (in Dollars) |
|
|
|
|
|
|
|
|
|
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,730,818
|
|
|
|
|
|
|
|
| Percentage of placement agent a fee |
|
|
|
|
|
|
|
|
7.00%
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds and expenses (in Dollars) |
|
|
|
|
|
|
|
|
$ 135,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants repriced per share (in Dollars per share) |
$ 0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued |
|
|
|
|
|
|
|
|
816,738
|
5,142,858
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of beneficial ownership limitation |
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercising warrants |
|
|
|
|
|
|
|
|
|
|
|
12,777,778
|
|
|
12,777,778
|
|
|
|
|
|
|
|
| Reduced exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.9
|
|
|
|
|
|
|
|
| Warrants term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
| Shares per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.9
|
|
|
|
|
|
|
|
| Warrants issued to investors (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17,233,000
|
|
|
|
|
|
|
|
| Equity issuance cost (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18,342,000
|
|
|
|
|
|
|
|
| Percentage of cash fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
| Aggregate shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
98,947,473
|
|
|
98,947,473
|
|
|
|
|
|
|
|
| Common stock reserved |
|
|
|
|
|
|
|
|
|
|
|
53,947,473
|
|
|
53,947,473
|
|
|
|
|
|
|
|
| Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
15,697,024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Term of exercisable |
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
$ 1.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,109,000
|
|
|
|
|
|
|
|
| Commencing date |
|
|
|
|
|
|
|
|
|
|
Jan. 17, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.199
|
|
|
|
|
|
|
|
| Weighted average period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years 2 months 23 days
|
|
|
|
|
|
|
|
| Common stock reserved |
|
|
|
|
|
|
|
|
|
|
|
53,947,473
|
|
|
53,947,473
|
|
|
|
|
|
|
|
| Warrants outstanding (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 4,579,195
|
|
|
$ 4,579,195
|
|
|
|
|
|
|
|
| Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
|
272,727
|
894,444
|
|
|
894,444
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
$ 1.65
|
|
|
|
|
|
|
|
|
|
|
|
| Expire date |
|
|
|
|
|
|
|
|
|
|
Jul. 17, 2030
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
$ 905,000
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of additional cash fee |
|
|
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
| May 2026 Warrant Inducement Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
12,777,778
|
|
|
|
|
|
|
|
|
|
511,111
|
|
|
511,111
|
|
|
|
|
|
|
|
| Common stock price per share (in Dollars per share) |
|
$ 0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
$ 1.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expire date |
|
|
|
|
|
|
|
|
|
|
|
Jun. 18, 2031
|
|
|
Jun. 18, 2031
|
|
|
|
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,730,000
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 903,000
|
|
|
|
|
|
|
|
| Commencing date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jun. 18, 2026
|
|
|
|
|
|
|
|
| Warrants issued |
|
|
|
|
|
|
|
|
|
|
6,818,182
|
|
|
|
|
|
|
|
|
|
|
|
| Shares per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.125
|
|
|
|
|
|
|
|
| Deducting placement agent fees and expenses (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,770,000
|
|
|
|
|
|
|
|
| 2024 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000,000
|
|
|
|
|
| Additional shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000,000
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
| Common stock par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
| Gross proceeds (in Dollars) |
|
|
|
|
|
|
|
$ 9,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent fee |
|
|
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants were exercised |
|
|
|
|
|
|
|
|
|
|
|
|
8,183,358
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
|
477,273
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
$ 1.65
|
|
|
|
|
|
|
|
|
|
|
|
| Expire date |
|
|
|
|
|
|
|
|
|
|
Jul. 17, 2030
|
|
|
|
|
|
|
|
|
|
|
|
| Commencing date |
|
|
|
|
|
|
|
|
|
|
Aug. 17, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
| Preferred stock par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
| Restricted Stock Units [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 1,702,348
|
|
|
5,074,630
|
|
|
|
|
|
|
|
| Restricted stock units |
|
|
350,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock awards date |
|
|
|
|
|
Sep. 19, 2028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unrecognized total compensation cost related to unvested restricted stock awards (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 15,224,629
|
|
|
$ 15,224,629
|
|
|
|
|
|
|
|
| Weighted average period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years 2 months 23 days
|
|
|
|
|
|
|
|
| Restricted Stock Units [Member] | Board of Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units |
|
|
|
|
|
11,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Units [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock on the date of grant (in Dollars) |
|
|
|
|
|
$ 20,300,000
|
|
|
|
|
|
|
|
|
$ 203,000
|
|
|
|
|
|
|
|
| Common stock on the date of grant per share (in Dollars per share) |
|
|
|
|
|
$ 1.75
|
|
|
|
|
|
|
|
|
$ 0.58
|
|
|
|
|
|
|
|
| Investor [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
$ 5,301,000
|
|
|
$ 8,197,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investors [Member] | May 2026 Warrant Inducement Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,555,556
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
5,142,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expire date |
|
|
|
Jan. 20, 2031
|
|
|
Mar. 10, 2031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
|
|
|
$ 7,619,854
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
$ 3,468,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
| Expenses of placement agent fee (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 85,000
|
|
|
|
|
|
|
|
| Commencing date |
|
|
|
|
|
|
Mar. 10, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock per share (in Dollars per share) |
|
|
|
|
|
|
$ 1.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering (in Dollars) |
|
|
|
|
|
|
$ 9,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds and expenses (in Dollars) |
|
|
|
|
|
|
|
|
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 1.09
|
|
|
$ 1.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expire date |
|
|
|
|
|
|
|
|
|
Mar. 10, 2031
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
$ 4,179,000
|
|
$ 6,995,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commencing date |
|
|
|
|
|
|
|
|
|
Mar. 10, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
205,714
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
$ 1.92
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expire date |
|
|
|
|
|
|
|
|
|
Mar. 10, 2031
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
$ 717,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commencing date |
|
|
|
|
|
|
|
|
|
Mar. 10, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of additional cash fee |
|
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
|
|
|
5,142,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
5,142,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] | Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
360,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
$ 2.1875
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
816,738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,513,762
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.09
|
|
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
$ 15,062,724
|
|
|
|
|
|
|
|
|
|
|
$ 818
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
$ 11,136,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering (in Dollars) |
|
|
|
$ 18,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants were exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,183,358
|
|
|
|
|
|
|
|
| Pre-funded warrants remain outstanding (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,046,000
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Term of exercisable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
| Expire date |
|
|
|
|
|
|
|
|
Dec. 08, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
1,155,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expire date |
|
|
|
|
|
|
|
|
Dec. 08, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
|
|
|
|
$ 1,401,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of additional cash fee |
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
15,229,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
15,229,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants exercisable |
|
|
|
15,229,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Investors Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
|
|
16,513,762
|
|
|
16,513,762
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13,196,000
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
1,284,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
1,284,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
$ 1.199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Common Stock [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 1.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
660,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
$ 1.3625
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Common Stock [Member] | Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 1.0899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IPO [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
|
|
|
|
6,818,182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| July 2025 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
$ 4,598,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| July 2025 Offering [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
6,818,182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 1.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| July 2025 Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
6,818,182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock price per share (in Dollars per share) |
|
|
|
|
|
|
|
$ 1.32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock Plans [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000,000
|
15,000,000
|
| Contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
| Stock-based compensation expense (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 1,858,443
|
|
$ 2,125,237
|
$ 5,968,921
|
$ 6,022,287
|
|
|
|
|
|
|
| Unrecognized total compensation cost (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 1,726,594
|
|
|
$ 1,726,594
|
|
|
|
|
|
|
|
| Unrecognized total compensation cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 year 5 months 1 day
|
|
|
|
|
|
|
|
| Minimum [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
|
| Maximum [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400,000,000
|
|
|
|